Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Antituberculous therapy along with steroids----[1] 84 💬
2Cyclophosphamide and steroids[1] Cyclophosphamide[2] Cyclophosphamide ,
Cyclophosphamide 💬 		--[1] 222 💬
3IV methylprednisolone (steroids)[1] Methylprednisolone[1] Methylprednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 13 💬
4Steroids----[7] 46, 50, 51, 63, 66, 96, 97 💬
5Steroids plus azathioprine[1] Azathioprine[1] Azathioprine 💬 --[1] 66 💬
6Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)[1] Human immunoglobulin G---[1] 11 💬
7Tocilizumab and IV steroids combination[1] Tocilizumab[1] Tocilizumab 💬 [1] IL6R 💬 [12] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬[1] 41 💬